Prospective unblinded randomized controlled trial of the effectiveness and safety of 30 W output and 50 W output in the cavotricuspid isthmus linear ablation for common atrial flutter

Prospective unblinded randomized controlled trial of the effectiveness and safety of 30 W output and 50 W output in the cavotricuspid isthmus linear ablation for common atrial flutter - compcarison of 30W output and 50W output inthe cavotricuspid isthmus linear ablation for common atrial flutter

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032751

Enrollment

Registered

2018-10-01

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

common atrial flutter

Interventions

Interventions: ablation at 50 W 10 - 12 seconds Control: ablation at 30 W 30 seconds

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Catheter ablation case for atrial fibrillation, atrial flutter

Exclusion criteria

Exclusion criteria: Recurrence case after ablation of tricuspid vena cavitalis previously performed History of congenital heart disease, heart surgery and cardiac tamponade

Design outcomes

Primary

Measure	Time frame
Total ablation time to make complete cavotricuspid isthmus blockline, total procedure time, incidence of complications	—

Countries

Japan

Contacts

Public ContactTatsuhiko Hirao

Yokohama City Minato Red Cross Hospital Cardiology

tatsuhiko1984@gmail.com045-628-6100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026